One of the prominent gaps in hematologic research ... What future innovations or policy changes do you believe could further streamline the implementation of bispecifics and CAR T-cell therapies ...
HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared ...
The changes were interpreted as those of early ... with otherwise normal results. Routine hematologic procedures, performed during the hospital visits, have shown persistent mild pancytopenia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback